Fundus autofluorescence, optical coherence tomography and electroretinography abnormalities in a patient with digoxin retinopathy that resemble those in KCNV2-associated retinopathy.
Digoxin
Electroretinogram
Fundus autofluorescence
Hyperkalemia
KCNV2
Optical coherence tomography
Journal
Documenta ophthalmologica. Advances in ophthalmology
ISSN: 1573-2622
Titre abrégé: Doc Ophthalmol
Pays: Netherlands
ID NLM: 0370667
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
09
03
2023
accepted:
21
06
2023
medline:
1
9
2023
pubmed:
18
7
2023
entrez:
17
7
2023
Statut:
ppublish
Résumé
Digoxin related retinal toxicity causes blurred vision, photophobia, central scotoma, color vision abnormality, and electroretinography (ERG) abnormalities. Here, we report a case with transient abnormalities in vison, in which fundus autofluorescence (FAF), optical coherence tomography (OCT), and ERG findings resembled those in KCNV2 (potassium voltage-gated channel modifier subfamily V member 2)-associated retinopathy. An 89-year-old woman presented with complaints of acute blurred vision, nyctalopia, photophobia, and color vision abnormality. She received digoxin for tachycardia induced by atrial fibrillation for a month. The fundi showed a faint white ring at the fovea, which showed hyperfluorescence in FAF. OCT showed a thickened EZ in the macula. A dark-adapted (DA)-30 ERG showed a reduced and "squaring (trough-flattened)" a-wave, and a delayed, supernormal b-wave, resulting in a high b/a-wave amplitude ratio. The digoxin dose was reduced following an elevation in serum levels. Five weeks later, her visual acuities improved, and abnormal hyperfluorescence on FAF disappeared. After 6 months, no visual symptoms were reported. The ellipsoid-zone thickening in OCT improved; however, the b/a-wave amplitude ratio on DA-30 ERG remained high. The b-wave in LA-long-flash ERG was initially reduced, which improved after correction of serum level of digoxin. The patient's clinical findings resembled those of patients with KCNV2-associated retinopathy or temporal hyperkalemia. These disorders appear to have a common pathogenesis, which may be related to abnormal extracellular potassium levels in the retina. The on-bipolar cells seemed to be more affected than the off-bipolar cells in digoxin related retinal toxicity.
Sections du résumé
BACKGROUND
Digoxin related retinal toxicity causes blurred vision, photophobia, central scotoma, color vision abnormality, and electroretinography (ERG) abnormalities. Here, we report a case with transient abnormalities in vison, in which fundus autofluorescence (FAF), optical coherence tomography (OCT), and ERG findings resembled those in KCNV2 (potassium voltage-gated channel modifier subfamily V member 2)-associated retinopathy.
CASE REPORT
An 89-year-old woman presented with complaints of acute blurred vision, nyctalopia, photophobia, and color vision abnormality. She received digoxin for tachycardia induced by atrial fibrillation for a month. The fundi showed a faint white ring at the fovea, which showed hyperfluorescence in FAF. OCT showed a thickened EZ in the macula. A dark-adapted (DA)-30 ERG showed a reduced and "squaring (trough-flattened)" a-wave, and a delayed, supernormal b-wave, resulting in a high b/a-wave amplitude ratio. The digoxin dose was reduced following an elevation in serum levels. Five weeks later, her visual acuities improved, and abnormal hyperfluorescence on FAF disappeared. After 6 months, no visual symptoms were reported. The ellipsoid-zone thickening in OCT improved; however, the b/a-wave amplitude ratio on DA-30 ERG remained high. The b-wave in LA-long-flash ERG was initially reduced, which improved after correction of serum level of digoxin.
CONCLUSIONS
The patient's clinical findings resembled those of patients with KCNV2-associated retinopathy or temporal hyperkalemia. These disorders appear to have a common pathogenesis, which may be related to abnormal extracellular potassium levels in the retina. The on-bipolar cells seemed to be more affected than the off-bipolar cells in digoxin related retinal toxicity.
Identifiants
pubmed: 37460904
doi: 10.1007/s10633-023-09942-x
pii: 10.1007/s10633-023-09942-x
doi:
Substances chimiques
Digoxin
73K4184T59
Potassium
RWP5GA015D
KCNV2 protein, human
0
Potassium Channels, Voltage-Gated
0
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
131-137Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Madreperla SA, Johnson MA, Nakatani K (1994) Electrophysiologic and electroretinographic evidence for photoreceptor dysfunction as a toxic effect of digoxin. Arch Ophthalmol 112:807–812. https://doi.org/10.1001/archopht.1994.01090180105044
doi: 10.1001/archopht.1994.01090180105044
pubmed: 8002841
Kinoshita J, Iwata N, Kimotsuki T, Yasuda M (2014) Digoxin-induced reversible dysfunction of the cone photoreceptors in monkeys. Invest Ophthalmol Vis Sci 55:881–892. https://doi.org/10.1167/iovs.13-13296
doi: 10.1167/iovs.13-13296
pubmed: 24436189
Weleber RG, Shults WT (1981) Digoxin retinal toxicity. Clinical and electrophysiologic evaluation of a cone dysfunction syndrome. Arch Ophthalmol 99:1568–1572. https://doi.org/10.1001/archopht.1981.03930020442007
doi: 10.1001/archopht.1981.03930020442007
pubmed: 7283806
Capellan P, Mahrous MA, Kovacs KD (2021) OCT findings in presumed digoxin retinal toxicity. Ophthalmology Retina 5:1173–1175. https://doi.org/10.1016/j.oret.2021.04.019
doi: 10.1016/j.oret.2021.04.019
pubmed: 33965642
Georgiou M, Fujinami K, Vincent A, Nasser F, Khateb S, Vargas ME et al (2021) KCNV2-associated retinopathy: detailed retinal phenotype and structural endpoints–KCNV2 study group report 2. Am J Ophthalmol 230:1–11. https://doi.org/10.1016/j.ajo.2021.03.004
doi: 10.1016/j.ajo.2021.03.004
pubmed: 33737031
pmcid: 8710866
Fujinami K, Tsunoda K, Nakamura N, Kato Y, Noda T, Shinoda K et al (2013) Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants. Mol Vis 19:1580–1590
pubmed: 23885164
pmcid: 3718491
Kaizuka C, Hayashi T, Mizobuchi K, Kubota M, Ueno S, Nakano T (2021) Transient electroretinographic abnormalities that mimic those of KCNV2 retinopathy: a case report. Doc Ophthalmol 143:221–228. https://doi.org/10.1007/s10633-021-09828-w
doi: 10.1007/s10633-021-09828-w
pubmed: 33738644
pmcid: 8494656
Hart NS, Mountford JK, Voigt V, Fuller-Carter P, Barth M, Nerbonne JM, et al (2019) The role of the voltage-gated potassium channel proteins Kv8.2 and Kv2.1 in vision and retinal disease: insights from the study of mouse gene knock-out mutations. eNeuro 6:e0032-19. https://doi.org/10.1523/ENEURO.0032-19.2019
Schmid V, Wurzel A, Wetzel CH, Plössl K, Bruckmann A, Luckner P et al (2022) Retinoschisin and novel Na/K-ATPase interaction partners Kv2.1 and Kv8.2 define a growing protein complex at the inner segments of mammalian photoreceptors. Cell Mol Life Sci 79:448. https://doi.org/10.1007/s00018-022-04409-9
doi: 10.1007/s00018-022-04409-9
pubmed: 35876901
pmcid: 9314279
Dhingra A, Sulaiman P, Xu Y, Fina ME, Veh RW, Vardi N (2008) Probing neurochemical structure and function of retinal ON bipolar cells with a transgenic mouse. J Comp Neurol 510:484–496. https://doi.org/10.1002/cne.21807
doi: 10.1002/cne.21807
pubmed: 18671302
pmcid: 2854669
Sulaiman P, Xu Y, Fina ME, Tummala SR, Ramakrishnan H, Dhingra A, et al (2013) Kir 2.4 surface expression and basal current are affected by heterotrimeric G-proteins. J Biol Chem 288:7420–7429. https://doi.org/10.1074/jbc.M112.412791
doi: 10.1074/jbc.M112.412791
pubmed: 23339194
pmcid: 3591649